Significantly, the scientists reported that enhanced differentiation of osteoblastic cells resulted in the growth of new, non-calcified bone-like matrix attached to the root furcation (the base of a tooth where two or more roots meet) by the osteoblasts. In their summary the scientists concluded that Drynaria could be a supplementary medicine for periodontal therapy based on its ability to reduce alveolar bone resorption while support the bone-building effects of osteoblasts. (8)